Joel Sng

发表

AIRE expression controls the peripheral selection of autoreactive B cells

C. Cunningham-Rundles, E. Meffre, P. Utz, 2019, Science Immunology.

Brief Report: Defective Early B Cell Tolerance Checkpoints in Sjögren's Syndrome Patients

E. Meffre, J. Gottenberg, A. Korganow, 2017, Arthritis & rheumatology.

PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein

J. Thiery, B. Goh, S. Choo, 2019, Nature Communications.

Emerging Stem Cell Therapies: Treatment, Safety, and Biology

T. Lufkin, Joel Sng, 2012, Stem cells international.

Targeting intra-viral conserved nucleocapsid (N) proteins as novel vaccines against SARS-CoVs

Q. Zeng, Joel Sng, Abhishek Gupta, 2021, Bioscience reports.

Advances in Stem Cell Therapies

T. Lufkin, Joel Sng, 2012 .

Positive and negative selection shape the human naive B cell repertoire

K. Schwarz, A. Schulz, E. Meffre, 2021, The Journal of clinical investigation.

Early B cell tolerance defects in neuromyelitis optica favour anti-AQP4 autoantibody production.

E. Meffre, S. Kleinstein, J. Bennett, 2019, Brain : a journal of neurology.

Antigen-mediated regulation in monoclonal gammopathies and myeloma.

D. Hose, B. Barlogie, N. Munshi, 2018, JCI insight.

In vivo genome-wide analysis of multiple tissues identifies gene regulatory networks, novel functions and downstream regulatory genes for Bapx1 and its co-regulation with Sox9 in the mammalian vertebral column

S. Prabhakar, Vibhor Kumar, P. Kraus, 2014, BMC Genomics.

Filling the Silent Void: Genetic Therapies for Hearing Impairment

T. Lufkin, Joel Sng, 2012, Genetics research international.